{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T04:39:01Z","timestamp":1777091941804,"version":"3.51.4"},"reference-count":60,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To develop of new class of selective and reversible MAO-B inhibitors from enamides.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Syntheses of the titled derivatives (AD1\u2013AD11) were achieved by reacting cinnamoyl chloride and various primary and secondary amines in basic medium. All eleven compounds were investigated for in vitro inhibitory activities against recombinant human MAO-A and MAO-B. The reversibilities of lead compound inhibitions were analysed by dialysis. MTT assays of lead compounds were performed using normal VERO cell lines.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Key findings<\/jats:title>\n                  <jats:p>Compounds AD3 and AD9 exhibited the greatest inhibitory activity against MAO-B with IC50 values of 0.11 and 0.10 \u00b5m, respectively, and were followed by AD2 and AD1 (0.51 and 0.71 \u00b5m, respectively). Most of the compounds weakly inhibited MAO-A, with the exceptions AD9 and AD7, which had IC50 values of 4.21 and 5.95 \u00b5m, respectively. AD3 had the highest selectivity index (SI) value for MAO-B (&amp;gt;363.6) and was followed by AD9 (SI 42.1). AD3 and AD9 were found to be competitive inhibitors of MAO-B with Ki values of 0.044 \u00b1 0.0036 and 0.039 \u00b1 0.0047 \u00b5m, respectively. Reversibility experiments showed AD3 and AD9 were reversible inhibitors of MAO-B; dialysis restored the activity of MAO-B to the reference level. MTT assays revealed AD3 and AD9 were non-toxic to normal VERO cell lines with IC50 values of 153.96 and 194.04 \u00b5g\/ml, respectively. Computational studies provided hypothetical binding modes for AD3 and AD9 in the binding cavities of MAO-A and MAO-B.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>These results encourage further studies on the enamide scaffold as potential drug candidates for the treatment of Alzheimer's and Parkinson's diseases.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1111\/jphp.13264","type":"journal-article","created":{"date-parts":[[2020,4,4]],"date-time":"2020-04-04T04:35:22Z","timestamp":1585974922000},"page":"916-926","source":"Crossref","is-referenced-by-count":22,"title":["Design of enamides as new selective monoamine oxidase-B inhibitors"],"prefix":"10.1093","volume":"72","author":[{"given":"Fathima Sahla","family":"Kavully","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Al-Shifa College of Pharmacy , Perinthalmanna,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong Min","family":"Oh","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, and Research Institute of Life Pharmaceutical Sciences, Sunchon National University , Suncheon,","place":["Korea"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanal","family":"Dev","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Al-Shifa College of Pharmacy , Perinthalmanna,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Swafvan","family":"Kaipakasseri","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Al-Shifa College of Pharmacy , Perinthalmanna,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashique","family":"Palakkathondi","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Al-Shifa College of Pharmacy , Perinthalmanna,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajeesh","family":"Vengamthodi","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Al-Shifa College of Pharmacy , Perinthalmanna,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rinshana Fathima","family":"Abdul Azeez","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Al-Shifa College of Pharmacy , Perinthalmanna,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Rita","family":"Tondo","sequence":"additional","affiliation":[{"name":"Instituto di Ricerche Farmacologiche Mario Negri IRCCS , Milano,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orazio","family":"Nicolotti","sequence":"additional","affiliation":[{"name":"Dipartimento di Farmacia\u2014Scienze del Farmaco, Universit\u00e0 degli Studi di Bari \u201cAldo Moro\u201d , Bari,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hoon","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, and Research Institute of Life Pharmaceutical Sciences, Sunchon National University , Suncheon,","place":["Korea"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6658-4497","authenticated-orcid":false,"given":"Bijo","family":"Mathew","sequence":"additional","affiliation":[{"name":"Division of Drug Design and Medicinal Chemistry Research Lab, Department of Pharmaceutical Chemistry, Ahalia School of Pharmacy , Palakkad,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,7,1]]},"reference":[{"key":"2024103012350982000_jphp13264-cit-0001","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2174\/0929867305666220314202430","article-title":"Structural aspects of monoamine oxidase and its reversible inhibition","volume":"5","author":"Wouters","year":"1998","journal-title":"Curr Med Chem"},{"key":"2024103012350982000_jphp13264-cit-0002","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.2174\/1381612811319140004","article-title":"Inhibitor design for monoamine oxidases","volume":"19","author":"Ramsay","year":"2013","journal-title":"Curr Pharm Des"},{"key":"2024103012350982000_jphp13264-cit-0003","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2174\/1573408012666160402001715","article-title":"Monoamine oxidase inhibitors: perspective design for the treatment of depression and neurological disorders","volume":"12","author":"Mathew","year":"2016","journal-title":"Curr Enzyme Inhib"},{"key":"2024103012350982000_jphp13264-cit-0004","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1517\/13543776.2010.495716","article-title":"Focusing on new monoamine oxidase inhibitors","volume":"20","author":"Bolasco","year":"2010","journal-title":"Expert Opin Ther Pat"},{"key":"2024103012350982000_jphp13264-cit-0005","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1002\/med.21561","article-title":"Monoamine oxidase-B inhibitors as potential neurotherapeutic agents: an overview and update","volume":"39","author":"Tripathi","year":"2019","journal-title":"Med Res Rev"},{"key":"2024103012350982000_jphp13264-cit-0006","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2174\/1389450117666151209123402","article-title":"A perspective on monoamine oxidase enzyme as drug target. Challenges and opportunities","volume":"18","author":"Kumar","year":"2017","journal-title":"Curr Drug Targets"},{"key":"2024103012350982000_jphp13264-cit-0007","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1517\/13543776.2014.982535","article-title":"Novel monoamine oxidase inhibitors: a patent review (2012\u20132014)","volume":"25","author":"Carradori","year":"2015","journal-title":"Expert Opin Ther Pat"},{"key":"2024103012350982000_jphp13264-cit-0008","doi-asserted-by":"crossref","first-page":"11645","DOI":"10.1002\/slct.201701213","article-title":"Refining the structural features of chromones as selective MAO-B inhibitors: exploration of combined pharmacophore-based 3D-QSAR and quantum chemical studies","volume":"2","author":"Mathew","year":"2017","journal-title":"ChemistrySelect"},{"key":"2024103012350982000_jphp13264-cit-0009","doi-asserted-by":"crossref","first-page":"811","DOI":"10.4155\/fmc-2017-0036","article-title":"Dual inhibitors of cholinesterases and monoamine oxidases for Alzheimer's disease","volume":"9","author":"Knez","year":"2017","journal-title":"Future Med Chem"},{"key":"2024103012350982000_jphp13264-cit-0010","doi-asserted-by":"crossref","first-page":"16404","DOI":"10.1038\/srep16404","article-title":"Early astrocytes in autosomal dominant Alzheimer's disease measured in vivo by multi-trace positron emission tomography","volume":"5","author":"Scholl","year":"2015","journal-title":"Sci Rep"},{"key":"2024103012350982000_jphp13264-cit-0011","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s11064-013-1137-6","article-title":"Selegiline reverses a\u03b225-35-induced cognitive deficit in male mice","volume":"38","author":"Pazini","year":"2013","journal-title":"Neurochem Res"},{"key":"2024103012350982000_jphp13264-cit-0012","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13195-017-0279-1","article-title":"Monoamine oxidase B is elevated in Alzheimer disease neurons, is associated with the \u03b3-secretase and regulates neuronal amloyd \u03b2-peptide levels","volume":"9","author":"Schedin-Weiss","year":"2017","journal-title":"Alzheimers Res Ther"},{"key":"2024103012350982000_jphp13264-cit-0013","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.201900177","article-title":"Emerging therapeutic potentials of dual-acting MAO and AChE inhibitors in Alzheimer's and Parkinson's diseases","volume":"352","author":"Mathew","year":"2019","journal-title":"Arch Pharm (Weinheim)"},{"key":"2024103012350982000_jphp13264-cit-0014","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1111\/jphp.13132","article-title":"Advancements in nanotherapeutics for Alzheimer's disease: current perspectives","volume":"71","author":"Harilal","year":"2019","journal-title":"J Pharm Pharmacol"},{"key":"2024103012350982000_jphp13264-cit-0015","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/S1474-4422(09)70293-5","article-title":"Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms","volume":"8","author":"Rodriguez-Oroz","year":"2009","journal-title":"Lancet Neurol"},{"key":"2024103012350982000_jphp13264-cit-0016","doi-asserted-by":"crossref","first-page":"911","DOI":"10.3390\/cells8080911","article-title":"The therapeutic implications of tea polyphenols against dopamine (DA) neuron degeneration in Parkinson's disease (PD)","volume":"8","author":"Zhou","year":"2019","journal-title":"Cells"},{"key":"2024103012350982000_jphp13264-cit-0017","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nrd2087","article-title":"Novel pharmacological targets for the treatment of Parkinson's disease","volume":"5","author":"Schapira","year":"2006","journal-title":"Nat Rev Drug Discov"},{"key":"2024103012350982000_jphp13264-cit-0018","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1126\/science.3080808","article-title":"Selectivity of the Parkinsonian neurotoxin MPTP: toxic metabolite MPP+ binds to neuromelanin","volume":"231","author":"D'Amato","year":"1986","journal-title":"Science"},{"key":"2024103012350982000_jphp13264-cit-0019","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1080\/13543776.2018.1427735","article-title":"MAO inhibitors and their wider applications: a patent review","volume":"28","author":"Carradori","year":"2018","journal-title":"Expert Opin Ther Pat"},{"key":"2024103012350982000_jphp13264-cit-0020","first-page":"404","article-title":"Structural features of Safinamide: a combined Hirshfeld surface analysis & quantum chemical treatment","volume":"17\u201316","author":"Joy","year":"2018","journal-title":"Chem Data Coll"},{"key":"2024103012350982000_jphp13264-cit-0021","doi-asserted-by":"crossref","first-page":"120","DOI":"10.2174\/1871524915666151002124443","article-title":"Monoamine oxidase inhibitory actions of chalcones. A mini review","volume":"16","author":"Mathew","year":"2016","journal-title":"Cent Nerv Syst Agents Med Chem"},{"key":"2024103012350982000_jphp13264-cit-0022","doi-asserted-by":"crossref","first-page":"6","DOI":"10.2174\/1871524919666190131160122","article-title":"Unraveling the structural requirements of chalcone chemistry towards monoamine oxidase inhibition","volume":"19","author":"Mathew","year":"2019","journal-title":"Cent Nerv Syst Agents Med Chem"},{"key":"2024103012350982000_jphp13264-cit-0023","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.bioorg.2015.07.001","article-title":"Development of fluorinated methoxylated chalcones as selective monoamine oxidase-B inhibitors: synthesis, biochemistry and molecular docking studies","volume":"62","author":"Mathew","year":"2015","journal-title":"Bioorg Chem"},{"key":"2024103012350982000_jphp13264-cit-0024","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1002\/cmdc.201600122","article-title":"Synthesis, biochemistry, and computational studies of brominated thienyl chalcones: a new class of reversible MAO-B inhibitors","volume":"11","author":"Mathew","year":"2016","journal-title":"ChemMedChem"},{"key":"2024103012350982000_jphp13264-cit-0025","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1002\/cmdc.201600497","article-title":"Monoamine oxidase inhibitory activity: methyl- versus chloro-chalcone derivatives","volume":"11","author":"Mathew","year":"2016","journal-title":"ChemMedChem"},{"key":"2024103012350982000_jphp13264-cit-0026","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/ardp.201600088","article-title":"Identification of indole based chalcones: discovery of potent, selective and reversible class of MAO-B inhibitors","volume":"349","author":"Sasidharan","year":"2016","journal-title":"Arch Pharm Chem Life Sci"},{"key":"2024103012350982000_jphp13264-cit-0027","doi-asserted-by":"crossref","first-page":"11113","DOI":"10.1002\/slct.201702141","article-title":"Characterization of thienylchalcones as hMAO-B inhibitors: synthesis, biochemistry and molecular dynamics studies","volume":"2","author":"Mathew","year":"2017","journal-title":"ChemistrySelect"},{"issue":"4","key":"2024103012350982000_jphp13264-cit-0028","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.201800309","article-title":"Potent and highly selective dual-targeting monoamine oxidase-B inhibitors: fluorinated chalcones of morpholine versus imidazole","volume":"352","author":"Mathew","year":"2019","journal-title":"Arch Pharm (Weinheim)"},{"key":"2024103012350982000_jphp13264-cit-0029","doi-asserted-by":"crossref","first-page":"522","DOI":"10.2174\/1386207320666170227155517","article-title":"Structural exploration of synthetic chromones as selective MAO-B inhibitors","volume":"20","author":"Mathew","year":"2017","journal-title":"Comb Chem High Throughput Screen"},{"key":"2024103012350982000_jphp13264-cit-0030","doi-asserted-by":"crossref","first-page":"5165","DOI":"10.1021\/jm2004267","article-title":"Chromone, a privileged scaffold for the development of monoamine oxidase inhibition","volume":"54","author":"Gaspar","year":"2011","journal-title":"J Med Chem"},{"key":"2024103012350982000_jphp13264-cit-0031","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.2174\/156802612805220002","article-title":"Focusing on new monoamine oxidase inhibitors: Differently substituted coumarins as an interesting scaffold","volume":"12","author":"Matos","year":"2012","journal-title":"Curr Top Med Chem"},{"key":"2024103012350982000_jphp13264-cit-0032","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2174\/1871524914666140129122632","article-title":"Pyrazoline. A promising scaffold for the inhibition of monoamine oxidase","volume":"13","author":"Mathew","year":"2013","journal-title":"Cent Nerv Syst Agents Med Chem"},{"key":"2024103012350982000_jphp13264-cit-0033","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.2174\/156802612805220057","article-title":"Discovery and optimization of pyrazoline derivatives as promising monoamine oxidase inhibitors","volume":"12","author":"Secci","year":"2012","journal-title":"Curr Top Med Chem"},{"key":"2024103012350982000_jphp13264-cit-0034","doi-asserted-by":"crossref","first-page":"6039","DOI":"10.1039\/C4CC10327K","article-title":"Exploring tertiary amides as versatile synthons in organic synthesis","volume":"51","author":"Mei-Xiang","year":"2015","journal-title":"Chem Commun (Camb)"},{"key":"2024103012350982000_jphp13264-cit-0035","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1039\/b809319a","article-title":"Enamides: valuable organic substrates","volume":"6","author":"Carbery","year":"2008","journal-title":"Org Biomol Chem"},{"key":"2024103012350982000_jphp13264-cit-0036","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ejmech.2015.10.051","article-title":"Anticonvulsant activity, crystal structures, and preliminary safety evaluation of N-trans-cinnamoyl derivatives of selected (un)modified aminoalkanols","volume":"107","author":"Gunia-Krzyz","year":"2016","journal-title":"Eur J Med Chem"},{"key":"2024103012350982000_jphp13264-cit-0037","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1021\/acs.jpcb.6b09451","article-title":"Pharmacophore based 3D-QSAR analysis of thienyl chalcone as new class of human MAO-B inhibitors. Investigation of combined quantum chemical and molecular dynamics approach","volume":"121","author":"Mathew","year":"2017","journal-title":"J Phys Chem B"},{"key":"2024103012350982000_jphp13264-cit-0038","doi-asserted-by":"crossref","first-page":"5162","DOI":"10.1016\/j.ejmech.2011.08.036","article-title":"Monoamine oxidase inhibition by selected anilide derivatives","volume":"46","author":"Legoabe","year":"2011","journal-title":"Eur J Med Chem"},{"key":"2024103012350982000_jphp13264-cit-0039","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1016\/j.bmcl.2012.02.090","article-title":"Synthesis and inhibitory effect of piperine derivatives on monoamine oxidases","volume":"22","author":"Mu","year":"2022","journal-title":"Bioorg Med Chem Lett"},{"key":"2024103012350982000_jphp13264-cit-0040","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1039\/C8MD00399H","article-title":"Selected aryl thiosemicarbazones as a new class of multi-targeted monoamine oxidase inhibitors","volume":"9","author":"Mathew","year":"2018","journal-title":"Med Chem Comm"},{"key":"2024103012350982000_jphp13264-cit-0041","doi-asserted-by":"crossref","first-page":"6614","DOI":"10.1002\/slct.201901093","article-title":"Ethoxylated head of chalcones as a new class of multi-targeted MAO inhibitors","volume":"4","author":"Lakshminarayanan","year":"2019","journal-title":"ChemistrySelect"},{"key":"2024103012350982000_jphp13264-cit-0042","doi-asserted-by":"crossref","first-page":"4714","DOI":"10.1016\/j.bmcl.2016.08.044","article-title":"Potent selective monoamine oxidase B inhibition by maackiain, a pterocarpan from the roots of Sophora flavescens","volume":"26","author":"Lee","year":"2016","journal-title":"Bioorg Med Chem Lett"},{"key":"2024103012350982000_jphp13264-cit-0043","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.bmcl.2018.01.049","article-title":"Selective inhibition of monoamine oxidase A by hispidol","volume":"28","author":"Baek","year":"2018","journal-title":"Bioorg Med Chem Lett"},{"key":"2024103012350982000_jphp13264-cit-0044","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.biopha.2018.06.064","article-title":"Imidazole bearing chalcones as new class of monoamine oxidase inhibitors","volume":"106","author":"Sasidharan","year":"2018","journal-title":"Biomed Pharmacother"},{"key":"2024103012350982000_jphp13264-cit-0045","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/ptr.5580","article-title":"Activation of cellular immunity in herpes simplex virus type 1- infected mice by the oral administration of aqueous extract of Moringa oleifera Lam. leaves","volume":"30","author":"Kurokawa","year":"2016","journal-title":"Phytother Res"},{"key":"2024103012350982000_jphp13264-cit-0046","doi-asserted-by":"crossref","first-page":"5739","DOI":"10.1073\/pnas.0710626105","article-title":"Structure of human monoamine oxidase A at 2.2-A resolution: the control of opening the entry for substrates\/inhibitors","volume":"105","author":"Son","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2024103012350982000_jphp13264-cit-0047","doi-asserted-by":"crossref","first-page":"5848","DOI":"10.1021\/jm070677y","article-title":"Structures of human monoamine oxidase B complexes with selective noncovalent inhibitors: safinamide and coumarin analogs","volume":"50","author":"Binda","year":"2007","journal-title":"J Med Chem"},{"key":"2024103012350982000_jphp13264-cit-0048","volume-title":"Schr\u00f6dinger Suite 2018-2 Protein Preparation Wizard","author":"Schr\u00f6dinger Release 2018-2","year":"2018"},{"key":"2024103012350982000_jphp13264-cit-0049","volume-title":"Schr\u00f6dinger","author":"LigPrep","year":"2018"},{"key":"2024103012350982000_jphp13264-cit-0050","volume-title":"Schr\u00f6dinger Suite 2018-2 QM-Polarized Ligand Docking Protocol","author":"Schr\u00f6dinger Release 2018-2","year":"2018"},{"key":"2024103012350982000_jphp13264-cit-0051","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ejps.2017.02.008","article-title":"A rational approach to elucidate human monoamine oxidase molecular selectivity of coumarin-based inhibitors","volume":"101","author":"Mangiatordi","year":"2017","journal-title":"Eur J Pharm Sci"},{"key":"2024103012350982000_jphp13264-cit-0052","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","article-title":"The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities","volume":"10","author":"Genheden","year":"2015","journal-title":"Expert Opin Drug Discov"},{"key":"2024103012350982000_jphp13264-cit-0053","volume-title":"Schr\u00f6dinger","author":"Prime","year":"2018"},{"key":"2024103012350982000_jphp13264-cit-0054","doi-asserted-by":"crossref","first-page":"103335","DOI":"10.1016\/j.bioorg.2019.103335","article-title":"Design, synthesis and biological evaluation of oxygenated chalcones as potent and selective MAO-B inhibitors","volume":"93","author":"Parambi","year":"2019","journal-title":"Bioorg Chem"},{"key":"2024103012350982000_jphp13264-cit-0055","doi-asserted-by":"crossref","first-page":"5561","DOI":"10.1021\/acs.jmedchem.5b00599","article-title":"Structure-based design and optimization of multitarget-directed 2H-chromen-2-one derivatives as potent inhibitors of monoamine oxidase B and cholinesterases","volume":"58","author":"Farina","year":"2015","journal-title":"J Med Chem"},{"key":"2024103012350982000_jphp13264-cit-0056","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.ijbiomac.2016.05.110","article-title":"Exploration of chlorinated thienyl chalcones: A new class of monoamine oxidase-B inhibitors","volume":"91","author":"Mathew","year":"2016","journal-title":"Int J Bio Macromol"},{"key":"2024103012350982000_jphp13264-cit-0057","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/j.ijbiomac.2017.05.162","article-title":"Monoamine oxidase inhibitory activities of methoxy substituted chalcones","volume":"104","author":"Mathew","year":"2017","journal-title":"Int J Bio Macromol"},{"key":"2024103012350982000_jphp13264-cit-0058","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.ijbiomac.2017.11.159","article-title":"Discovery of potent and reversible MAO-B inhibitors as furanochalcones","volume":"108","author":"Suresh","year":"2018","journal-title":"Int J Bio Macromol"},{"key":"2024103012350982000_jphp13264-cit-0059","doi-asserted-by":"crossref","first-page":"4568","DOI":"10.2174\/092986711797379302","article-title":"Targeting monoamine oxidases with multipotent ligands: An emerging strategy in the search of new drugs against neurodegenerative diseases","volume":"18","author":"Pisani","year":"2011","journal-title":"Curr Med Chem"},{"key":"2024103012350982000_jphp13264-cit-0060","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3390\/molecules21030362","article-title":"Searching for multi-targeting neurotherpeutics against Alzheimer's. Discovery of potent AChE-MAO-B inhibitors through the decoration of 2H-chromen-2-one structural motif","volume":"21","author":"Pisani","year":"2016","journal-title":"Molecules"}],"container-title":["Journal of Pharmacy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjphp.13264","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jphp.13264","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jphp.13264","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/72\/7\/916\/60226256\/jphp13264.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/72\/7\/916\/60226256\/jphp13264.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T17:59:34Z","timestamp":1730311174000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jpp\/article\/72\/7\/916\/6122180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,1]]},"references-count":60,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2020,7,1]]},"published-print":{"date-parts":[[2020,7,1]]}},"URL":"https:\/\/doi.org\/10.1111\/jphp.13264","relation":{},"ISSN":["0022-3573","2042-7158"],"issn-type":[{"value":"0022-3573","type":"print"},{"value":"2042-7158","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,7]]},"published":{"date-parts":[[2020,7,1]]}}}